Nanalysis Scientific Corp. (1N1.F)
| Previous Close | 0.2340 |
| Open | 0.2380 |
| Bid | 0.2380 x N/A |
| Ask | 0.2680 x N/A |
| Day's Range | 0.2380 - 0.2380 |
| 52 Week Range | 0.2280 - 0.4320 |
| Volume | |
| Avg. Volume | 416 |
| Market Cap | 28.821M |
| Beta (5Y Monthly) | 0.77 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1200 |
| Earnings Date | Apr 25, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CNW GroupNanalysis Announces Full Year 2023 Conference Call
Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces that on Thursday, April 25th, 2024, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter and year ending December 31, 2023.
CNW GroupNanalysis Scientific Corp. Announces Director Resignation
Nanalysis Scientific Corp. ("Nanalysis" or the "Company", (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) announces that Kham Lin has resigned as a director of the Company effective April 9, 2024, and the Board of Directors has accepted his resignation. The Company would like to thank Mr. Lin for his contributions throughout his tenure as director of the Company.
CNW GroupNanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances
Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, announces that its subsidiary Nanalysis Corp. is receiving advisory services and up to $1.45 million in non-repayable, non-dilutive funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), to develop Artificial Intelligence based so
